Portal Hypertensive Biliopathy as a Cause of Severe Cholestasis in Children With Congenital Hepatic Fibrosis


DALGIÇ A. , SARI S. , SÖZEN M. H. , Kaya N. G. , DALGIÇ B.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION, vol.17, pp.223-225, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17
  • Publication Date: 2019
  • Doi Number: 10.6002/ect.mesot2018.p79
  • Title of Journal : EXPERIMENTAL AND CLINICAL TRANSPLANTATION
  • Page Numbers: pp.223-225

Abstract

Portal hypertensive biliopathy may occur in patients with noncirrhotic hepatic fibrosis. Portal hypertensive biliopathy treatment should be focused on management of portal hypertension and relief of biliary obstruction. In patients with noncirrhotic portal fibrosis and symptomatic portal hypertensive biliopathy, portal decompression surgery by proximal splenorenal shunt is one successful treatment option.